Exploring the molecular pathways linking sleep phenotypes and POGZ-associated neurodevelopmental disorder

Area of Science:

• Genetics
• Neurodevelopmental Disorders
• Sleep Medicine

Background:

• Rare variants in the POGO transposable element-derived with ZNF domain (POGZ) gene are associated with neurodevelopmental disorders, including White-Sutton syndrome.
• Clinical features often include developmental delay, autism spectrum disorder, obesity, and frequently, sleep disturbances.
• The molecular mechanisms linking POGZ gene function to sleep phenotypes remain largely unknown.

Purpose of the Study:

• To investigate sleep disturbances in individuals with POGZ variants.
• To identify molecular pathways and genes connecting POGZ function to sleep regulation.
• To explore potential therapeutic targets for sleep issues in POGZ-associated syndromes.

Main Methods:

• Screening of sleep implications in patients with known causative POGZ variants.
• Identification of POGZ regulatory targets associated with sleep traits.
• Pathway enrichment analysis on the intersection of POGZ targets and sleep-related genes.

Main Results:

• Sleep disturbances were reported in 52% of patients with POGZ variants.
• Obesity was not identified as a risk factor for sleep problems in this cohort.
• Pathway analysis revealed enrichment in circadian rhythm regulation, tau protein binding, and ATPase activator activity.

Conclusions:

• POGZ variants contribute to sleep disturbances through disruption of specific molecular pathways.
• Circadian rhythm regulation and related pathways are implicated in POGZ-associated sleep phenotypes.
• Further research into these shared mechanisms could inform novel therapeutic strategies.